Who is sponsoring NCT02831244?

NCT02831244 is sponsored by Smith & Nephew, Inc..

What drugs are being tested in NCT02831244?

Interventions in NCT02831244: Agili-CTM.

What condition does NCT02831244 study?

NCT02831244 studies Osteoarthritis of Multiple Joints of Ankle or Foot.

Is NCT02831244 still recruiting?

NCT02831244 is currently completed. Last updated 6 March 2025.

Last reviewed 2025-03-06 · How we verify

NCT02831244

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Agili-CTM Implant Performance Evaluation in the Treatment of Osteoarthritis of the Great Toe

Completed NA Last updated 6 March 2025

What this trial tests

NA trial testing Agili-CTM in Osteoarthritis of Multiple Joints of Ankle or Foot in 20 participants. Completed in 23 June 2019.

Timeline

10 August 2016

Primary endpoint
23 June 2019

23 June 2019

Quick facts

Lead sponsor	Smith & Nephew, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	10 August 2016
Primary completion	23 June 2019
Estimated completion	23 June 2019
Sites	4 locations across Serbia, Italy, Slovenia, Israel

Drugs / interventions tested

Agili-CTM

Conditions studied

Osteoarthritis of Multiple Joints of Ankle or Foot — all drugs for Osteoarthritis of Multiple Joints of Ankle or Foot →

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

18 and older, any sex, with Osteoarthritis of Multiple Joints of Ankle or Foot. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the performance of the Agili-CTM implant in the treatment of osteoarthritis of the Great Toe.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis of Multiple Joints of Ankle or Foot

Currently open trials in the same condition.

NCT03781544 — Effects of Opioids and NSAIDs on Sympathetic Nervous System and Vascular Function · Phase 4 · recruiting

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

NCT07025304 — Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate · NA · recruiting
NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02831244 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
Last refreshed: 6 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02831244.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing